Pembrolizumab-Induced Axial Spondyloarthritis

Ann Pharmacother. 2024 May;58(5):555-556. doi: 10.1177/10600280231181400. Epub 2023 Jun 26.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / adverse effects
  • Axial Spondyloarthritis*
  • Humans
  • Spondylitis, Ankylosing*

Substances

  • pembrolizumab
  • Antibodies, Monoclonal, Humanized